PROSPER: A Multinational, Phase III, Randomized, Double-Blind, Placebo-Controlled, Efficacy And Safety Study Of Enzalutamide In Patients With Nonmetastatic Castration-Resistant Prostate Cancer

UCI-14-50
NCT02003924
Cancer - Prostate
Edward Uchio
Open
Treatment
III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.